Author Correction: Primary endocrine resistance of ER+ breast cancer with ESR1 mutations interrogated by droplet digital PCR (npj Breast Cancer, (2022), 8, 1, (58), 10.1038/s41523-022-00424-y)

Sung Gwe Ahn, Soong June Bae, Yoonjung Kim, Jung Hwan Ji, Chihhao Chu, Dooreh Kim, Janghee Lee, Yoon Jin Cha, Kyung A. Lee, Joon Jeong

Research output: Contribution to journalComment/debatepeer-review

Abstract

In this article the funding from ‘This study was supported by Alvogen Korea.’ was omitted in the Acknowledgement. The original article has been corrected.

Original languageEnglish
Article number67
Journalnpj Breast Cancer
Volume8
Issue number1
DOIs
Publication statusPublished - 2022 Dec

Bibliographical note

Funding Information:
In this article the funding from ‘This study was supported by Alvogen Korea.’ was omitted in the Acknowledgement. The original article has been corrected.

Publisher Copyright:
© The Author(s) 2022.

All Science Journal Classification (ASJC) codes

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Author Correction: Primary endocrine resistance of ER+ breast cancer with ESR1 mutations interrogated by droplet digital PCR (npj Breast Cancer, (2022), 8, 1, (58), 10.1038/s41523-022-00424-y)'. Together they form a unique fingerprint.

Cite this